OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The fusion proteins TEL-PDGFR and FIP1L1-PDGFR escape ubiquitination and degradation
Federica Toffalini, Anders Kallin, Peter Vandenberghe, et al.
Haematologica (2009) Vol. 94, Iss. 8, pp. 1085-1093
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Multiple oligomerization domains of KANK1-PDGFR are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK
Sandrine Medves, Laura A. Noël, Carmen P. Montano‐Almendras, et al.
Haematologica (2011) Vol. 96, Iss. 10, pp. 1406-1414
Open Access | Times Cited: 22

FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia
Junko Iwasaki, Takeshi Kondo, Stephanie Darmanin, et al.
Annals of Hematology (2014) Vol. 93, Iss. 9, pp. 1473-1481
Open Access | Times Cited: 21

The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway
Alexandra Coomans de Brachène, Emeline Bollaert, Astrid Eijkelenboom, et al.
Biochemical Journal (2014) Vol. 460, Iss. 1, pp. 25-36
Closed Access | Times Cited: 19

HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation
Emeline Bollaert, Manuel Johanns, Gaëtan Herinckx, et al.
Cellular Signalling (2018) Vol. 44, pp. 158-170
Closed Access | Times Cited: 18

Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice
Samuel J. Taylor, Christine B.F. Thien, Samantha A. Dagger, et al.
Experimental Hematology (2014) Vol. 43, Iss. 3, pp. 191-206.e1
Open Access | Times Cited: 16

The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1‐PDGFRα and PDGFRα D842V
Laura A. Noël, Florence A. Arts, Carmen P. Montano‐Almendras, et al.
Molecular Oncology (2014) Vol. 8, Iss. 3, pp. 728-740
Open Access | Times Cited: 15

Novel COL4A1‐VEGFD gene fusion in myofibroma
Guillaume Dachy, S. Fraitag, Boutaina Boulouadnine, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 9, pp. 4387-4394
Open Access | Times Cited: 11

Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation
Ayaka Sugiura, Katherine L. Beier, Channing Chi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

PDGFRA K385 mutants in myxoid glioneuronal tumors promote receptor dimerization and oncogenic signaling
Laurence de Villenfagne, Ariane Sablon, Jean‐Baptiste Demoulin
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

A germline PDGFRB splice site variant associated with infantile myofibromatosis and resistance to imatinib
Boutaina Boulouadnine, Mathilde Filser, Camille Leducq, et al.
Genetics in Medicine (2024) Vol. 27, Iss. 2, pp. 101334-101334
Closed Access | Times Cited: 1

Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Xudong Li, Wei Li, Yanli Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101150-101150
Open Access | Times Cited: 3

The oncogenic FIP1L1-PDGFRαfusion protein displays skewed signaling properties compared to its wild-type PDGFRαcounterpart
Serge Haan, Christelle Bahlawane, Jiali Wang, et al.
JAK-STAT (2015) Vol. 4, Iss. 1, pp. e1062596-e1062596
Open Access | Times Cited: 5

Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activities
Makoto Ibata, Junko Iwasaki, Yoichiro Fujioka, et al.
Cancer Science (2016) Vol. 108, Iss. 2, pp. 200-207
Open Access | Times Cited: 4

Functional overlap of inborn errors of immunity and metabolism genes defines T cell metabolic vulnerabilities
Andrew R. Patterson, Gabriel A. Needle, Ayaka Sugiura, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Closed Access

Identification of a novel PHIP::BRAF gene fusion in infantile fibrosarcoma
Boutaina Boulouadnine, Laurence de Villenfagne, Christine Galant, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 11, pp. 678-682
Closed Access | Times Cited: 2

MTHFD2 is a Metabolic Checkpoint Controlling Effector and Regulatory T Cell Fate and Function
Ayaka Sugiura, Gabriela Andrejeva, Kelsey Voss, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Molecular genetics of the myeloproliferative neoplasms
Philip Beer
(2016), pp. 80-132
Closed Access

Targeting the PDGF signaling pathway in tumor
Carl‐Henrik Heldin
(2013)
Closed Access

Androgen Signaling Restricts Glutaminolysis to Drive Sex-Specific Th17 Metabolism
Nowrin U. Chowdhury, Jacqueline-Yvonne Cephus, Matthew Z. Madden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Antieosinophil Therapeutics

Elsevier eBooks (2012), pp. 577-605
Closed Access

Previous Page - Page 2

Scroll to top